Abstract
BackgroundTenofovir alafenamide (TAF) is a novel tenofovir (TFV) prodrug that, when administered in the single tablet regimen E/C/F/TAF, has >90% lower plasma TFV levels compared to tenofovir disoproxil fumarate (TDF).MethodsTreatment...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have